Works matching IS 22812075 AND DT 2022 AND VI 10 AND IP 5

Results: 6

Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review.
Published in:
Health Psychology Research, 2022, v. 10, n. 5, p. 1, doi. 10.52965/001c.38536
By:
- Cornett, Elyse M.;
- Nemomsa, Meskerem A.;
- Turbeville, Bailey;
- Busby, Matthew A.;
- Kaye, Jessica S.;
- Kaye, Aaron J.;
- JooHee Choi;
- Ramírez, Giovanni F.;
- Varrassi, Giustino;
- Kaye, Adam M.;
- Kaye, Alan D.;
- Wilson, James;
- Ganti, Latha
Publication type:
Article
Rimegepant for the treatment of migraine.
Published in:
Health Psychology Research, 2022, v. 10, n. 5, p. 1, doi. 10.52965/001c.38534
By:
- Berger, Amnon A.;
- Winnick, Ariel;
- Carroll, Austin H.;
- Welschmeyer, Alexandra;
- Li, Nathan;
- Colon, Marc;
- Paladini, Antonella;
- Ramírez, Giovanni F.;
- Hasoon, Jamal;
- Cornett, Elyse M.;
- Song, Jaehong;
- Varrassi, Giustino;
- Kaye, Adam M.;
- Kaye, Alan D.;
- Ganti, Latha
Publication type:
Article
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.
Published in:
Health Psychology Research, 2022, v. 10, n. 5, p. 1, doi. 10.52965/001c.36074
By:
- Berger, Amnon A.;
- Winnick, Ariel;
- Izygon, Jonathan;
- Jacob, Binil M.;
- Kaye, Jessica S.;
- Kaye, Rachel J.;
- Neuchat, Elisa E.;
- Kaye, Adam M.;
- Alpaugh, Edward S.;
- Cornett, Elyse M.;
- Han, Andrew H.;
- Kaye, Alan D.
Publication type:
Article
Glossopharyngeal Neuralgia: Epidemiology, Risk factors, Pathophysiology, Differential diagnosis, and Treatment Options.
Published in:
Health Psychology Research, 2022, v. 10, n. 5, p. 1, doi. 10.52965/001c.36042
By:
- Han, Andrew;
- Montgomery, Carver;
- Zamora, Alexandra;
- Winder, Emilie;
- Kaye, Adam;
- Carroll, Caroline;
- Aquino, Alfonso;
- Kakazu, Juyeon;
- Kaye, Alan D.
Publication type:
Article
deutetrabenazine for the treatment of chorea associated with Huntington's disease.
Published in:
Health Psychology Research, 2022, v. 10, n. 5, p. 1, doi. 10.52965/001c.36040
By:
- Gupta, Harshit;
- Perkins, Wil;
- Stark, Cain;
- Kikkeri, Sathya;
- Kakazu, Juyeon;
- Kaye, Adam;
- Kaye, Alan D.
Publication type:
Article
A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine.
Published in:
Health Psychology Research, 2022, v. 10, n. 5, p. 1, doi. 10.52965/001c.34265
By:
- Noor, Nazir;
- LaChute, Courtney;
- Root, Mathew;
- Rogers, Jasmine;
- Richard, Madeleine;
- Varrassi, Giustino;
- Urits, Ivan;
- Viswanath, Omar;
- Khater, Nazih;
- Kaye, Alan D.
Publication type:
Article

Works matching IS 22812075 AND DT 2022 AND VI 10 AND IP 5

Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review.

Rimegepant for the treatment of migraine.

Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.

Glossopharyngeal Neuralgia: Epidemiology, Risk factors, Pathophysiology, Differential diagnosis, and Treatment Options.

deutetrabenazine for the treatment of chorea associated with Huntington's disease.

A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine.